Lixoft SAS

Where the EU money came from

Funding by EU programme. Amounts are Lixoft SAS's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• IDEA-FASTPartner

  Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

  Horizon 2020 · 2019–2026 · Project on CORDIS ↗

  €243ktheir share
• DDMOREPartner

  Drug Disease Model Resources

  FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

  €271ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Astrazeneca ABSweden · 2 shared projects
• F. Hoffmann-La Roche AGSwitzerland · 2 shared projects
• Eli Lilly and Company LtdUnited Kingdom · 2 shared projects
• Pfizer LimitedUnited Kingdom · 2 shared projects
• Takeda Pharmaceuticals International AGSwitzerland · 2 shared projects
• The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 1 shared project
• Consiglio Nazionale Delle RicercheItaly · 1 shared project
• Imperial College of Science Technology and MedicineUnited Kingdom · 1 shared project
• University College LondonUnited Kingdom · 1 shared project
• Teknologian Tutkimuskeskus VTT OyFinland · 1 shared project
• Uppsala UniversitetSweden · 1 shared project
• The University of ManchesterUnited Kingdom · 1 shared project
• Universiteit LeidenNetherlands · 1 shared project
• European Molecular Biology LaboratoryGermany · 1 shared project
• University College Cork - National University of Ireland, CorkIreland · 1 shared project
• Erasmus Universitair Medisch Centrum RotterdamNetherlands · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• ecosystems
• inflammatory diseases
• mathematical model
• ontology
• public health
• sleep disorders
• software